In this episode of Focus on Fertility, we are joined by Sarah Cross, PhD, Associate Scientific Director of Women’s Health at Abbvie, to discuss a revolutionary new medication assisting patients with endometriosis pain, Orilissa. Orilissa is the first FDA approved oral medication developed specifically for women with moderate to severe endometriosis pain in more than a decade. Tune in and learn how the medication may assist you in reducing the symptoms associated with 3 common types of endometriosis pain:

Painful Periods (dysmenorrhea)

Pelvic Pains in between Periods (non-menstrual pelvic pain)

Pain with Sex (dyspareunia)

Additional information regarding Orilissa is available at orilissa.com